Yingqing Liang

机构：Guangxi University

发表论文 16 篇 · 总被引 666 次 · h-index 10

代表论文

• Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer (2020 · Cellular and Molecular Immunology · 被引 260)
• Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma (2019 · Journal for ImmunoTherapy of Cancer · 被引 129)
• Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer (2017 · Immunologic Research · 被引 68)
• Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer (2017 · OncoTargets and Therapy · 被引 48)
• Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer (2017 · Molecular Immunology · 被引 41)
• Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study (2017 · Cancer Biology & Therapy · 被引 35)